Article
Adaptive immunity is required for durable responses to alectinib in murine models of…
medRxiv · 2022 · Emily K. Kleczko
Key facts
| Title | Adaptive immunity is required for durable responses to alectinib in murine models of EML4-ALK lung cancer |
|---|---|
| First author | Emily K. Kleczko |
| Journal | medRxiv |
| Published | Apr 14, 2022 |
| DOI | 10.1101/2022.04.14.488385 |
| Devices mentioned | BK110039, DEN000008, K010696, K022086, K103302, K202641, K231013 |
| Product codes mentioned | JCI, JJH, JQP, KIT, MVU, NDS, NJT, OOI, PFF, PFT, JIS, PCA and 1 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1